Gabriel Brooks, MD, MPH, of Dartmouth Geisel School of Medicine (IMAGE)
Caption
Alliance A232402 CD: PAGODA-Randomized Trial of a Proactive Graduated Dose Modification Algorithm for FOLFOX Chemotherapy to Prevent Unplanned Delays
Led by Gabriel Brooks, MD, MPH, of Dartmouth Geisel School of Medicine, this trial will test PAGODA, the Proactive Graduated Dose Modification Algorithm. It’s a structured plan that helps doctors make small, proactive changes to chemotherapy doses to prevent treatment delays. Instead of reacting after severe side effects occur, PAGODA guides doctors to act early, keeping patients on schedule and reducing stress and delays. The trial is enrolling patients with cancer of the esophagus, gastroesophageal junction, stomach, small intestine, appendix, colon, rectum, and cancers of unknown primary with suspected GI origin.
Credit
Dartmouth Geisel School of Medicine
Usage Restrictions
none
License
Original content